Calendar

Filter Events

FILTER BY MONTH

October 2024

21
Oct
Mon, 10/21/2024 - 00:00
WEBINAR

Rethinking Schizophrenia: Prioritizing Cognitive Symptoms in Schizophrenia Care

A Pre-Approval Information Exchange (PIE) Webinar, sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. 

Join a comprehensive webinar that will enhance your decision-making for people living with schizophrenia. This webinar will delve into a disease overview of schizophrenia, shedding light on the often overlooked cognitive symptom domain and its significant clinical and economic burden. The webinar will also uncover the latest understanding of the biological mechanisms and explore a potential new treatment approach to specifically target cognitive symptoms associated with schizophrenia. 

This webinar is only offered to payers, formulary committees, or other similar entities responsible for the selection of drugs for coverage or reimbursement. In order to join this webinar, you must be registered as a user of FormularyDecisions®. This product is in the clinical evaluation stage and has not been approved for use by the FDA. The safety and efficacy of this product have not been established.

Monday, Oct. 21, 2024 | 2–3pm ET

October 2024

23
Oct
Wed, 10/23/2024 - 00:00
WEBINAR

A CGRP Receptor Antagonist for the Acute Treatment of Migraine: Focus on Early Treatment

A Science & Innovation Webinar, presented by Abbvie. 

One of the main goals of acute treatment of migraine is freedom from pain and associated symptoms without recurrence. It is therefore important that every person with migraine, regardless of migraine frequency, be offered a migraine specific treatment that has freedom from pain data, freedom from associated symptom data and evidence that the treatment can prevent a moderate to severe migraine attack. The objective for this webinar is to review the migraine disease state and phases of a migraine attack, and outline clinical data as a treatment option for the acute treatment of migraine.

Wednesday, Oct. 23, 2024 | 2–3pm ET

October 2024

24
Oct
Thu, 10/24/2024 - 00:00
WEBINAR

Preapproval Information Exchange in Radicular Leg Pain Associated with Lumbar Disc Herniation

A Pre-Approval Information Exchange (PIE) Webinar, sponsored by Ferring Pharmaceuticals, Inc.

SI-6603 is an investigational product being evaluated for the treatment of radicular leg pain associated with lumbar disc herniation. This pre-approval information exchange (PIE) presentation includes disease overview, an overview of SI-6603 including MOA and pivotal study data along with anticipated timing and access details.

This webinar is only offered to payers, formulary committees, or other similar entities responsible for the selection of drugs for coverage or reimbursement. In order to join this webinar, you must be registered as a user of FormularyDecisions®.

This product is in the clinical evaluation state and has not been approved for use by the FDA. The safety and efficacy of this product have not been established.

Thursday, Oct. 24, 2024 | 2–3pm ET

October 2024

30
Oct
Wed, 10/30/2024 - 00:00
WEBINAR

Vutrisiran Pre-Approval Information Exchange (PIE) Webinar

A Pre-Approval Information Exchange (PIE) Webinar, presented by Alnylam Pharmaceuticals, Inc.

Transthyretin amyloidosis (ATTR) is an underdiagnosed, progressive, debilitating and fatal disease caused by misfolded transthyretin (TTR) proteins, which accumulate as amyloid deposits in various parts of the body, including the heart, nerves, and gastrointestinal tract. Please join Alnylam Pharmaceuticals as we review the disease state, clinical symptoms and epidemiology for the Cardiomyopathy manifestation of the disease followed by a review of the study results for the Phase 3 HELIOS-B trial.

This webinar is only offered to payers, formulary committees, or other similar entities responsible for the selection of drugs for coverage or reimbursement. In order to join this webinar, you must be registered as a user of FormularyDecisions®.

This product is in the clinical evaluation stage and has not been approved for use by the FDA. The safety and efficacy of this product have not been established.

Wednesday, Oct. 30, 2024 | 2–3pm ET

November 2024

1
Nov
Fri, 11/01/2024 - 00:00
OTHER EVENT

Steven G. Avey Award Application Deadline

The Steven G. Avey Award recognizes a health care professional for sustained, exemplary and distinguished service to the practice of managed care pharmacy.

Nominate a deserving individual who has made meaningful and impactful contributions to the field today!

Applications Close Nov. 1, 2024

November 2024

6
Nov
Wed, 11/06/2024 - 00:00
WEBINAR

A Preventive Treatment Option for Adults with Migraine

A Science & Innovation Webinar, presented by Abbvie.

Migraine is a complex, chronic disease that results in significant patient and economic burden. It is important to appropriately manage a person with migraine who experiences greater than 4 attacks a month (or severe disability from at least two attacks a month) and may benefit from preventive therapy. One of the main goals of preventive therapy is to improve function and reduce disability. Utilizing a stratified care approach to preventive migraine treatment is key to accomplish this goal. During this webinar, a migraine expert will discuss the complexity of migraine disease and the burden of the disease as it relates to function, and the treatment landscape, with a focus on a preventive treatment option for adults with migraine.

Wednesday, Nov. 6, 2024 | 12–1pm ET

November 2024

7
Nov
Thu, 11/07/2024 - 00:00
OTHER EVENT

Mid-South AMCP Biosimilar Implementation

Thursday, Nov. 7, 2024 | 6–8:30pm CT

November 2024

7
Nov
Thu, 11/07/2024 - 00:00
WEBINAR

Application of Indirect Treatment Comparisons

A Science & Innovation Webinar, presented by Abbvie.

The intent of evidence-based health care decision making is to compare all applicable and available treatment options. When direct comparisons from randomized controlled trials are not available, indirect treatment comparisons, including network meta-analyses, may offer valuable insights. In addition, mixed treatment comparisons, a type of network meta-analysis, combine both direct and indirect evidence for specific comparisons, providing a broader view than traditional network meta analysis.

Thursday, Nov. 7, 2024 | 12–1pm ET

November 2024

12-13
Nov
2024
OTHER EVENT

Partnership Forum – Closing the Gap in Real-World Evidence Use: A Collaborative Approach for Health Care Transformation

Real-world evidence (RWE) is increasingly used to support epidemiologic studies, safety and effectiveness studies, and even contribute to clinical trials or as evidence included in regulatory submissions. However, RWE has a much less prominent role in payer decision-making, particularly due to challenges such as a lack of standards and guidelines for how to evaluate and use RWE, lack of experience in applying RWE to formulary decisions, and lack of understanding how RWE could be most impactful for payer decisions. AMCP is developing standards and resources to support RWE interpretation and application to formulary and medical policy decisions. These standards aim to align RWE definitions, improve the transparency in RWE generation, increase consistency in how sponsors develop and share RWE, and support the ongoing communication between payers and pharmaceutical manufacturers. 

This Partnership Forum will convene multi-stakeholder experts to develop resources that will address barriers to RWE use in formulary decision-making through workshop and collaborative activities that will result in a set of RWE standards and tools to facilitate stakeholder communication and streamline the use of RWE. 

November 2024

14
Nov
Thu, 11/14/2024 - 00:00
OTHER EVENT

Mountain West Pharmacy Summit: "Prescription for Progress: Exploring the Future of Pharmacy and Patient Access"

The purpose of the Mountain West AMCP Pharmacy Summit is to bring together pharmacists in various roles in Utah and Nevada to educate, collaborate, and engage. We will hear perspectives from local and national leaders from various pharmacy perspectives. Students, fellows, residents, faculty, and other researchers will have the opportunity to present their new or encore research and network with leaders.

Thursday, November 14, 2024 from 9:30am–4pm PT

November 2024

14
Nov
Thu, 11/14/2024 - 00:00
OTHER EVENT

Carolinas Day of Education 2024

Thursday, Nov. 14 from 8am–4pm ET

November 2024

21
Nov
Thu, 11/21/2024 - 00:00
WEBINAR

AMCP Foundation Research Pre-Symposium Webinar: Access, Affordability, and Adherence: Addressing Disparities in Medication Use

The invite-only webinar aims to enhance the upcoming AMCP Foundation Research Symposium. Gain invaluable insights with virtual breakout sessions, laying the foundation for impactful face-to-face discussions and networking prospects.

Thursday, Nov. 21, 2024

November 2024

22
Nov
Fri, 11/22/2024 - 00:00
OTHER EVENT

Midwest AMCP 2024 Chicago Day of Education

Join Midwest AMCP and your peers for education and networking at this popular Midwest AMCP Day of Education on Friday, November 22, in Chicago, IL. 

Friday, November 22, 2024 at 7:30am-2:00pm CT

December 2024

03-04
Dec
2024
OTHER EVENT

AMCP Foundation Research Symposium: Access, Affordability and Adherence: Addressing Disparities in Medication Use

The invite-only symposium's structure, which will include plenary sessions, working breakout discussions, and the active capture of ideas and solutions, aims to provide participants with the opportunity to deliver on:

A roadmap that identifies concrete steps that individual stakeholders can implement in the short, medium, and longer terms to reduce disparities in medication use, access, and affordability and; 

Conceptualization of learning networks across stakeholders that will take the recommendations in the Roadmap and collaborate together to make strides in implementing the identified steps.

Dec. 3–4 2024
Dallas, Texas

December 2024

9
Dec
Mon, 12/09/2024 - 00:00
WEBINAR

Hepatitis C Elimination in the US: Progress and the Path Forward

A Science & Innovation Webinar, presented by Abbvie. 

An overview of the impact and burden of Hepatitis C virus in the US, treatment landscape, elimination progress, access restrictions, and the health economics of curative treatment. 

This program will review: 

  • Disease state pathophysiology, burden and impact of untreated Hepatitis C in the US. 
  • The WHO HCV elimination targets and the progress to date. 
  • The current treatment landscape and the AASLD/IDSA guideline recommendations for the treatment of HCV. 
  • The current state of access to HCV treatments and the health economics of curative treatment.
Monday, Dec. 9, 2024 | 2–3pm ET

March 2025

31-03
Mar
2025
NATIONAL MEETING

AMCP 2025

  • Registration opens for AMCP 2025 in Houston on December 3, 2024. 
  • Call for Session Proposals Submission Portal Open August 19-September 23, 2024.
  • Call for Poster Abstracts Submission Portal Open August 19-October 31, 2024.
March 31–April 3, 2025
George R Brown Convention Center, Houston TX

October 2025

27-30
Oct
2025
NATIONAL MEETING

AMCP Nexus 2025

Oct. 27–30, 2025
Gaylord National Harbor, National Harbor, MD

April 2026

13-16
Apr
2026
NATIONAL MEETING

AMCP 2026

April 13–16, 2026
Music City Center, Nashville, TN

October 2026

26-29
Oct
2026
NATIONAL MEETING

AMCP Nexus 2026

Oct. 26-29, 2026
Gaylord Pacific, San Diego, CA

April 2027

13-16
Apr
2027
NATIONAL MEETING

AMCP 2027

April 13–16, 2027
Moscone West Convention Center, San Francisco, CA

October 2027

18-21
Oct
2027
NATIONAL MEETING

AMCP Nexus 2027

Oct. 18-21, 2027
Orlando World Center Marriott, Orlando FL

March 2028

20-23
Mar
2028
NATIONAL MEETING

AMCP 2028

Mar. 20-23, 2028
Henry B Gonzalez Convention Center, San Antonio, TX

October 2028

09-12
Oct
2028
NATIONAL MEETING

AMCP Nexus 2028

Oct. 9-12, 2028
Gaylord Rockies, Aurora, CO